This is an old revision of this page, as edited by Beetstra (talk | contribs) at 12:34, 6 December 2011 (Saving copy of the {{drugbox}} taken from revid 460148751 of page Ranibizumab for the Chem/Drugbox validation project (updated: 'ChEMBL', 'KEGG').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 12:34, 6 December 2011 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 460148751 of page Ranibizumab for the Chem/Drugbox validation project (updated: 'ChEMBL', 'KEGG').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This page contains a copy of the infobox ({{drugbox}}) taken from revid 460148751 of page Ranibizumab with values updated to verified values. |
| Monoclonal antibody | |
|---|---|
| Type | Fab fragment |
| Source | Humanized (from mouse) |
| Target | VEGFA |
| Clinical data | |
| Trade names | Lucentis |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a607044 |
| License data |
|
| Routes of administration | Intravitreal injection |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Elimination half-life | Approx. 9 days |
| Identifiers | |
| CAS Number | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C2158H3282N562O681S12 |
| Molar mass | 48000dalton g·mol |
| (what is this?) (verify) | |
- Lucentis Prescribing Information. Genentech. June 2010.